| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2013 | CN101619043B Quinazoline derivant and medical application thereof |
| 06/05/2013 | CN101616595B Semi-fluid food product comprising beta-glucan fibres |
| 06/05/2013 | CN101597280B Compound used as seven-pass transmembrane protein and based on sag structure |
| 06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 06/05/2013 | CN101580871B Method for screening new drug for lowering cholesterol based on analysis of change of NPC1L1 protein subcellular localization |
| 06/05/2013 | CN101573123B Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
| 06/05/2013 | CN101563351B Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/05/2013 | CN101553480B Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 06/05/2013 | CN101553473B Substituted pyrazoles, compositions containing these, method of production and use |
| 06/05/2013 | CN101535328B New derivatives of 5-thioxilopyranose |
| 06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
| 06/05/2013 | CN101528214B Substituted acylanilides and methods of use thereof |
| 06/05/2013 | CN101522186B Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 06/05/2013 | CN101516891B Dihydrothieno pyrimidines as AKT protein kinase inhibitors |
| 06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
| 06/05/2013 | CN101433565B Total alkaloid extract of seeds of harmel genus, and preparation thereof |
| 06/05/2013 | CN101400336B Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 06/05/2013 | CN101355947B Thiazolopyrimidines for use in therapy |
| 06/05/2013 | CN101353655B siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof |
| 06/05/2013 | CN101336920B Stable medicine combination |
| 06/05/2013 | CN101244154B Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
| 06/05/2013 | CN101193889B Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
| 06/05/2013 | CN101160402B Cancer specific antibody and cell surface proteins |
| 06/05/2013 | CN101155923B Method for producing probiotically derived compounds |
| 06/05/2013 | CN101141964B Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/05/2013 | CN101108840B Chirality anona squamosa L. lactone compound with conformation limitation structure and synthesizing method and use thereof |
| 06/04/2013 | US8455688 HDAC inhibitors |
| 06/04/2013 | US8455687 Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies |
| 06/04/2013 | US8455686 Compounds for treating proliferative disorders |
| 06/04/2013 | US8455667 Duloxetine compositions in the form of a powder for suspension in a liquid |
| 06/04/2013 | US8455665 3-phenoxymethylpyrrolidine compounds |
| 06/04/2013 | US8455662 Formulations for benzimidazolyl pyridyl ethers |
| 06/04/2013 | US8455658 Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| 06/04/2013 | US8455656 Kinase inhibitors |
| 06/04/2013 | US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
| 06/04/2013 | US8455652 Inhibitors for the soluble epoxide hydrolase |
| 06/04/2013 | US8455645 Pyrrolopyridine derivatives and their use as CRTH2 antagonists |
| 06/04/2013 | US8455553 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease and transplant rejection |
| 06/04/2013 | US8455552 Composition comprising S-allylmercapto-N-acetylcysteine (ASSNAC) for up-regulation of cellular glutathione level |
| 06/04/2013 | US8455551 Broad spectrum disinfectant |
| 06/04/2013 | US8455550 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products |
| 06/04/2013 | US8455549 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 06/04/2013 | US8455548 Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists |
| 06/04/2013 | US8455547 Substituted cyclopentanes having prostaglandin activity |
| 06/04/2013 | US8455545 Liquid pest control formulation |
| 06/04/2013 | US8455544 Synthetic triterpenoids and methods of use in the treatment of disease |
| 06/04/2013 | US8455543 Platinum complexes and methods for inhibiting tumor cell proliferation |
| 06/04/2013 | US8455542 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 06/04/2013 | US8455541 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 06/04/2013 | US8455540 Gossypol and apogossypol derivatives, preparation thereof and uses thereof |
| 06/04/2013 | US8455539 CCI-779 concentrate formulations |
| 06/04/2013 | US8455538 Augmented cognitive training |
| 06/04/2013 | US8455537 Estrogen receptor modulators and uses thereof |
| 06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/04/2013 | US8455535 Heteroaryl dihydroindolones as kinase inhibitors |
| 06/04/2013 | US8455534 Estrogen receptor modulators and uses thereof |
| 06/04/2013 | US8455533 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 06/04/2013 | US8455531 Amino acid compositions |
| 06/04/2013 | US8455530 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
| 06/04/2013 | US8455529 Kinase inhibitors |
| 06/04/2013 | US8455528 Imidazole derivatives useful as inhibitors of FAAH |
| 06/04/2013 | US8455527 Methods of treatment using a dexmedetomidine premix formulation |
| 06/04/2013 | US8455526 Therapeutic use of imidazole-5-carboxylic acid derivatives |
| 06/04/2013 | US8455525 Selective androgen receptor modulators |
| 06/04/2013 | US8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions |
| 06/04/2013 | US8455523 Compositions and methods for treating hyperlipidemias |
| 06/04/2013 | US8455522 Benzoxazolone derivatives as aldosterone synthase inhibitors |
| 06/04/2013 | US8455521 Diaminoalkane aspartic protease inhibitors |
| 06/04/2013 | US8455520 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 06/04/2013 | US8455519 Drug active in neuropathic pain |
| 06/04/2013 | US8455518 Method of treating skin with microRNA modulators |
| 06/04/2013 | US8455517 Method of using diketopiperazines and composition containing them |
| 06/04/2013 | US8455516 HIV-1 fusion inhibitors and methods |
| 06/04/2013 | US8455515 Kidney and respiratory system disorders; central nervous system disorders; brain disorders; sleep disorders; strokes; psychological disorders |
| 06/04/2013 | US8455514 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 06/04/2013 | US8455513 Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide |
| 06/04/2013 | US8455512 Therapeutic pyrazolyl thienopyridines |
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/04/2013 | US8455510 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 06/04/2013 | US8455509 Method for the preparation of morphine compounds |
| 06/04/2013 | US8455508 Sustained release parenteral formulations of buprenorphine |
| 06/04/2013 | US8455507 Aminopyrimidines useful as kinase inhibitors |
| 06/04/2013 | US8455506 Quinazoline based EGFR inhibitors containing a zinc binding moiety |
| 06/04/2013 | US8455505 Pyrrolopyrimidinedione and its therapeutic use |
| 06/04/2013 | US8455504 Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance |
| 06/04/2013 | US8455502 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes |
| 06/04/2013 | US8455501 N-(5-cycloalkyl)-pyridin-3-yl carboxamides |
| 06/04/2013 | US8455500 3-hydroxy-5-arylisoxazole derivative |
| 06/04/2013 | US8455499 Alkyne antagonists of lysophosphatidic acid receptors |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455497 Inhibitors of aspartyl protease |
| 06/04/2013 | US8455496 Benzofuranyl derivatives |
| 06/04/2013 | US8455495 Pyridazino-pyridinone compounds and methods of use |
| 06/04/2013 | US8455494 Preparations and methods for ameliorating or reducing presbyopia |
| 06/04/2013 | US8455493 Imidazopyrazine Syk inhibitors |
| 06/04/2013 | US8455492 Methods for treating retinal diseases |
| 06/04/2013 | US8455491 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine and derivatives and pharmaceutical compositions comprising the same |
| 06/04/2013 | US8455490 Facially amphiphilic polymers and oligomers and uses thereof |
| 06/04/2013 | US8455489 Substituted pyrimidine compositions and methods of use |